Friday 6 November 2026 Export BBNX’s income statement to Excel — free account

Beta Bionics, Inc.

BBNX Healthcare Medical Devices

Beta Bionics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $100.3 million, up 53.9% from fiscal 2024.

Revenue: +30.3%
EPS: −58.6%
Free cash flow: −45.5%

Quarter to September 2026, against a year earlier

15.72 0.23 +1.48%

Follow BBNX

Alert me

Market cap: $842.1M
P/E: 0.0×
Fwd P/E: −8.2×
Dividend yield: —
F-score: 5/9
Altman Z: 16.89
Beneish M: −1.86
Dividend safety: n/a

Overview

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	(23.88%)	(26.16%)	(22.71%)	(346.51%)	+8 more TTM periods Free account
ROA Full definition →	(21.48%)	(23.45%)	(20.68%)	(30.60%)
ROIC Full definition →	(35.92%)	(68.47%)	(67.46%)	(65.51%)
Return on Tangible Assets Full definition →	(30.57%)	(33.82%)	(28.28%)	(29.81%)
Average Days of Receivables Full definition →	59.27	55.37	52.15	62.32
Free Cash Flow per Share Full definition →	(7.36)	(7.59)	(7.60)	(8.22)
Free Cash Flow Full definition →	(342.70)	(338.15)	(337.86)	(332.96)
Capital Expenditures Full definition →	(283.33)	(282.34)	(283.08)	(282.03)
Other line items
Cash ROIC Full definition →	(53.41%)	(77.39%)	(71.75%)	(65.69%)
Accounts Receivable Turnover Full definition →	7.90	8.08	8.89	6.89
Accounts Payable Turnover Full definition →	11.52	11.31	16.37	11.39
Inventory Turnover Full definition →	2.43	2.41	2.39	2.55
Average Days of Payables Full definition →	32.46	39.37	17.91	40.80
Days of Inventory on Hand Full definition →	159.25	175.97	183.35	177.32
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	33.55%	32.70%	34.07%	34.70%
Selling, General and Administrative Expense of Revenue Full definition →	97.82%	95.36%	93.21%	92.20%
Share Based Compensation of Revenue Full definition →	18.42%	17.82%	17.22%	16.34%
Operating CF/Net income Full definition →	0.71	0.76	0.82	0.70
Depreciation/Fixed assets Full definition →	0.56	0.52	0.32	0.33
Capex/Depreciation Full definition →	(42.90)	(50.11)	(86.89)	(98.10)
Revenue per Share Full definition →	2.73	2.67	2.48	2.47
Operating CF per Share Full definition →	(1.28)	(1.25)	(1.23)	(1.26)
Capex per Share Full definition →	(6.09)	(6.34)	(6.37)	(6.96)
Capex to Sales Full definition →	2.23	2.37	2.57	2.81

Show all line items

Columns are period end dates · fundamentals updated 2 Nov 2026

Stockrow Weekly